Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Juratli

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 6, 2017
[Chronic subdural hematoma in the elderly]T A Juratli, J Klein, G Schackert
Der Anaesthesist|January 23, 2015
[Acute treatment of patients with severe traumatic brain injury]T A Juratli, S E Stephan, A E Stephan, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 10, 2016
[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases]A Perrakis, T A Juratli, W Hohenberger, et al.
Journal of Neuro-Oncology|September 28, 2012
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomasT A Juratli, M Kirsch, K Geiger, et al.
Acta Neuropathologica Communications|August 6, 2024
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutationJ Steininger, C Buszello, R Oertel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 6, 2017
[Chronic subdural hematoma in the elderly]T A Juratli, J Klein, G Schackert
Der Anaesthesist|January 23, 2015
[Acute treatment of patients with severe traumatic brain injury]T A Juratli, S E Stephan, A E Stephan, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 10, 2016
[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases]A Perrakis, T A Juratli, W Hohenberger, et al.
Journal of Neuro-Oncology|September 28, 2012
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomasT A Juratli, M Kirsch, K Geiger, et al.
Acta Neuropathologica Communications|August 6, 2024
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutationJ Steininger, C Buszello, R Oertel, et al.
Pageof 1